Puma Biotechnology (PBYI) Interest Expenses (2018 - 2026)

Puma Biotechnology (PBYI) has 16 years of Interest Expenses data on file, last reported at $4.2 million in Q1 2026.

• Quarterly Interest Expenses fell 56.77% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 56.77% YoY) and the FY2025 annual result came in at $9.7 million, down 97.18% from the prior year.
• Interest Expenses advanced to $4.2 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $10.4 million in Q2 2024 to a low of $1.6 million in Q4 2025.
• A 5-year average of $7.3 million and a median of $9.7 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses slumped 82.57% — and 2025, when it jumped 453.65%.
• Tracing PBYI's Interest Expenses over 5 years: stood at $2.0 million in 2022, then jumped by 409.87% to $10.2 million in 2023, then tumbled by 77.65% to $2.3 million in 2024, then retreated by 28.65% to $1.6 million in 2025, then jumped by 157.08% to $4.2 million in 2026.
• The last three Interest Expenses figures came in at $4.2 million (Q1 2026), $1.6 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.